← Scroll for more →
Anavex Life Sciences Corp. (AVXL)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.30
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.00
P/B Ratio
1083.33
Institutional Ownership
40.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.06M | $20.0M | 8.69% | +446.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.05M | $10.0M | 4.37% | +190.6K | 2026-06-30 |
| Two Sigma Investments, LP | 3.05M | $7.0M | 3.29% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 2.41M | $6.0M | 2.60% | +219.2K | 2026-06-30 |
| State Street Corp | 1.92M | $4.0M | 2.07% | -2.59M | 2026-06-30 |
| Federated Hermes, Inc. | 1.07M | $2.0M | 1.16% | +539.6K | 2026-06-30 |
| AQR Capital Management LLC | 963.0K | $2.0M | 1.04% | +206.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 948.6K | $2.0M | 1.02% | +165.5K | 2026-06-30 |
| Summit Financial, LLC | 909.4K | $2.0M | 0.98% | -31.0K | 2026-06-30 |
| Goldman Sachs Group Inc | 890.6K | $2.0M | 0.96% | +86.2K | 2026-06-30 |